Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
2
33%
Ph not_applicable
2
33%
Ph phase_3
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (33.3%)
Phase 32 (33.3%)
N/A2 (33.3%)

Trials by Status

not_yet_recruiting117%
completed350%
unknown233%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

NCT02831959
not_yet_recruitingnot_applicable

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

NCT06716775
completednot_applicable

Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19

NCT04465513
completedphase_3

Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma

NCT01655693
unknownphase_2

Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

NCT04351724
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02831959Phase 3

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Completed
NCT06716775Not Applicable

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

Not Yet Recruiting
NCT04465513Not Applicable

Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19

Completed
NCT01655693Phase 3

Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma

Completed
NCT04351724Phase 2

Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

Unknown
NCT01755624Phase 2

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Unknown

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6